| RS1592116886 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1592117125 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1592117677 |
CD27
|
Health Risk |
Pathogenic |
Immunodeficiency, Combined immunodeficiency |
| RS1592118753 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS1592118879 |
ARID2
|
Health Risk |
Pathogenic |
— |
| RS1592118927 |
ARID2
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 6, Coffin-Siris syndrome 6 |
| RS1592118953 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1592118976 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1592119138 |
KMT2D
|
Health Risk |
Likely pathogenic |
Lymphoma, Lymphoma |
| RS1592121202 |
ARID2
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 6, Medulloblastoma non-WNT/non-SHH group 4 |
| RS1592121317 |
ARID2
|
Health Risk |
Pathogenic |
— |
| RS1592121752 |
ARID2
|
Health Risk |
Pathogenic |
— |
| RS1592122640 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1592123024 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1592123162 |
KMT2D
|
Health Risk |
Pathogenic |
Lymphoma, Kabuki syndrome 1 |
| RS1592129081 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1592129138 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1592130816 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1592131106 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1592131399 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS1592132971 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1592133086 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Malignant tumor of urinary bladder |
| RS1592133696 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1592135715 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1592136242 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1592136317 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome |
| RS1592136884 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1592137369 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1592137413 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1592138822 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome 1 |
| RS1592139221 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Nasopharyngeal carcinoma |
| RS1592139573 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1592141343 |
WNK1
|
Health Risk |
Pathogenic |
Pseudohypoaldosteronism type 2C, Neuropathy |
| RS1592142093 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1592142239 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1592143384 |
ZEB1
|
Health Risk |
Pathogenic |
Posterior polymorphous corneal dystrophy 3, Posterior polymorphous corneal dystrophy 3 |
| RS1592145571 |
ARID2
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 6, Coffin-Siris syndrome 6 |
| RS1592145939 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1592146526 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1592148206 |
SCN8A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1592149711 |
SCN8A
|
Health Risk |
Likely pathogenic |
Cognitive impairment with or without cerebellar ataxia, Cognitive impairment with or without cerebellar ataxia |
| RS1592149771 |
SCN8A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 13 |
| RS1592149793 |
SCN8A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 13 |
| RS1592149876 |
SCN8A
|
Health Risk |
Likely pathogenic |
— |
| RS1592149906 |
SCN8A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1592150075 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1592151169 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1592152233 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1592153986 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Branchial cleft anomaly |
| RS1592156633 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1592157134 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS1592157335 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1592157505 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1592159322 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1592159924 |
KMT2D
|
Health Risk |
Pathogenic/Likely pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1592160494 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1592161182 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1592162415 |
SCN8A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 13 |
| RS1592162430 |
SCN8A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 13 |
| RS1592162506 |
SCN8A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1592162768 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1592162790 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1592164705 |
SCN8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1592166720 |
ABCC9
|
Health Risk |
Likely pathogenic |
Hypertrichotic osteochondrodysplasia Cantu type, Dilated cardiomyopathy 1O |
| RS1592168824 |
WNK1
|
Health Risk |
Conflicting classifications of pathogenicity |
WNK1-related disorder, Pseudohypoaldosteronism type 2C |
| RS1592169234 |
KRT6B
|
Health Risk |
Pathogenic |
Pachyonychia congenita 4, Pachyonychia congenita 4 |
| RS1592173638 |
HNRNPA1
|
Health Risk |
Likely pathogenic |
Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3, Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3 |
| RS1592174304 |
SCN8A
|
Health Risk |
Likely pathogenic |
Seizure, Infantile spasms |
| RS1592184934 |
DHH
|
Health Risk |
Pathogenic |
46, XY sex reversal 7 |
| RS1592192920 |
COL2A1
|
Health Risk |
Pathogenic |
Platyspondylic dysplasia, Torrance type |
| RS1592193619 |
KRT5
|
Health Risk |
Pathogenic |
— |
| RS1592196064 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome, type I |
| RS1592196744 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS1592196867 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS1592197682 |
COL2A1
|
Health Risk |
Likely pathogenic |
Spondyloepiphyseal dysplasia, Stanescu type |
| RS1592197752 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS1592198747 |
COL2A1
|
Health Risk |
Likely pathogenic |
Spondyloepiphyseal dysplasia, Stanescu type |
| RS1592198803 |
COL2A1
|
Health Risk |
Likely pathogenic |
Spondyloperipheral dysplasia, Spondyloperipheral dysplasia |
| RS1592199296 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1592199342 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS1592202517 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS1592205758 |
COL2A1
|
Health Risk |
Likely pathogenic |
Stickler syndrome type 1, COL2A1-related disorder |
| RS1592206729 |
COL2A1
|
Health Risk |
Likely pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS1592212904 |
HMBS
|
Health Risk |
Pathogenic |
Porphyria, acute intermittent |
| RS1592213590 |
HMBS
|
Health Risk |
Pathogenic/Likely pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS1592214208 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS1592214400 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1592214498 |
HMBS
|
Health Risk |
Pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS1592215081 |
HMBS
|
Health Risk |
Likely pathogenic |
— |
| RS1592215117 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS1592215837 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS1592217071 |
COL2A1
|
Health Risk |
Likely pathogenic |
Stickler syndrome, Stickler syndrome |
| RS1592217625 |
HMBS
|
Health Risk |
Pathogenic |
Abnormal circulating porphyrin concentration, Abnormal circulating porphyrin concentration |
| RS1592217645 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS1592217847 |
HMBS
|
Health Risk |
Pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS1592217853 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS1592218346 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Stargardt disease, Stickler syndrome type 1 |
| RS1592218614 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1592219635 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS1592219658 |
HMBS
|
Health Risk |
Pathogenic |
— |